Journal of Tissue Engineering and Reconstructive Surgery ›› 2023, Vol. 19 ›› Issue (2): 184-.

Previous Articles     Next Articles

Application progress of mesenchymal stem cells and their exosomes in allotransplantation

  

  • Online:2023-04-01 Published:2023-05-10

Abstract:

Long term administration of immunosuppressive therapies is required in solid organ transplantation (SOT) and
vascularized composite allotransplantation (VCA). However, medication of combined immunosuppressants will result in multiple
organ toxicities, and even threaten lives. Mesenchymal stem cells and their exosomes are proved to be effective to control acute
allograft rejection and induce tolerance as a cell therapy. In this paper, the mesenchymal stem cells and their exosomes in SOT
and VCA were reviewed.

Key words:

composite allotransplantation